333 mg Acamprosate Calcium Tablet
Acamprosate Calcium Tablet, Delayed Release
Product Images NDC 60687-121
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Acamprosate Calcium (NDC 60687-121). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by American Health Packaging, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Blister
Carton
NDC 60687-121-25 is a prescription drug containing 30 delayed-release tablets of Acamprosate Calcium. Each tablet is enteric-coated and contains USP Acamprosate calcium. The usual dosage details are available in the package insert. The drug should be stored at temperatures ranging from 20°C to 25°C, and the excursions are permitted between 15 to 30°C. The drug manufacturer is Glenmark Pharmacautical Inc., and the drug is distributed by American Health Packaging. The package contains important instructions like keeping it out of children's reach, not to be used if the blister is torn or broken.*
Structure
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
